Health journal
Evidence-based articles, reviewed by pharmacists.
TRTTestosterone replacement therapy: guidelines, not guesswork
TRT is real medicine for men with confirmed hypogonadism. Here is what current guidelines say about diagnosis, monitoring and risk.
HormonesHormone therapy at menopause: the 2023 position statement
HRT is the most effective treatment for vasomotor symptoms. Where it helps most, who should be cautious, and how bioidentical compounding fits.
TRTMonitoring TRT: bloods that should never be skipped
Why haematocrit, hormone levels and cardiovascular risk markers are essential checkpoints — not optional extras.
LongevityLongevity science: what genuinely moves the needle
Caloric restriction, exercise, sleep, social connection. The fundamentals versus the hype around NAD+, NMN and senolytics.
Sports and healthRecovery, peptides and the line WADA draws
Athletes want faster recovery. Here is why several 'recovery peptides' are prohibited in sport — and how to accelerate recovery within the rules.
Sports and healthExercise as medicine: dose, type and the minimum that counts
The WHO physical activity guideline is the simplest 'prescription' in health. Here is what compliance means and how to start sustainably.
RetatrutideRetatrutide: what the early evidence actually says
A triple-hormone agonist under investigation for obesity and metabolic disease. Where the science stands, its limitations, and why it is not yet approved for clinical use.
Home CareHome healthcare: what good looks like in the UAE
As home care grows across the GCC, demand rises with an ageing population. What separates quality home care from the rest.
PeptidesPeptides in modern medicine: from insulin to GLP-1 and beyond
A century after insulin, therapeutic peptides are quietly reshaping diabetes, obesity and chronic care. Here is what is evidence-based, and what is not.
IV TherapyIV vitamin therapy: what the evidence supports, and what doesn't
Drip bars are popular, but most healthy people get no proven benefit. Clinical screening matters more than the menu of add-ons.
IV TherapyWho benefits from IV therapy, and who should wait
A concise clinical guide: the patients who may benefit, the red flags that mean delay, and why we won't book a drip without screening.
LongevityNAD+, NMN and senolytics: evidence to date
A plain-language update on some of the most-hyped longevity candidates, and the gap between pre-clinical promise and approved clinical use.